These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 5083554

  • 21. Effects of inhibitors on drug metabolism.
    Netter KJ.
    Drug Metab Dispos; 1973; 1(1):162-3. PubMed ID: 4149378
    [No Abstract] [Full Text] [Related]

  • 22. Aminopyrine demethylase. Kinetic evidence for multiple microsomal activities.
    Pederson TC, Aust SD.
    Biochem Pharmacol; 1970 Jul; 19(7):2221-30. PubMed ID: 5520370
    [No Abstract] [Full Text] [Related]

  • 23. Comparative studies on hepatic N- and O-demethylation.
    Otsuji H, Imamura T, Ikeda M.
    Jpn J Pharmacol; 1972 Aug; 22(4):561-70. PubMed ID: 4539508
    [No Abstract] [Full Text] [Related]

  • 24. Effect of phenobarbital on the metabolism and serotonin-depleting action of 4-chloro-beta, beta-difluoroamphetamine in rats.
    Fuller RW, Baker JC, Perry KW, Molloy BB.
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):274-8. PubMed ID: 4851682
    [No Abstract] [Full Text] [Related]

  • 25. Protective effect of drug metabolism inducer and inhibitor on O,O,S-trimethyl phosphorothioate induced delayed toxicity in rats.
    Imamura T.
    Proc West Pharmacol Soc; 1984 Apr; 27():155-61. PubMed ID: 6494150
    [No Abstract] [Full Text] [Related]

  • 26. The possible role of cytochrome P-450 in the liver "first pass elimination" of a beta-receptor blocking drug.
    Grundin R, Moldéus P, Orrenius S, Borg KO, Skånberg I, von Bahr C.
    Acta Pharmacol Toxicol (Copenh); 1974 Sep; 35(3):242-60. PubMed ID: 4479306
    [No Abstract] [Full Text] [Related]

  • 27. The enzymatic formation of bilirubin.
    Schmid R, McDonagh AF.
    Ann N Y Acad Sci; 1975 Apr 15; 244():533-52. PubMed ID: 1094885
    [No Abstract] [Full Text] [Related]

  • 28. Liver microsomal metabolism of N-methylcarbazole: a probe for induction, inhibition, and species differences.
    Koop DR, Hollenberg PF.
    Mol Pharmacol; 1980 Jan 15; 17(1):118-27. PubMed ID: 7383014
    [No Abstract] [Full Text] [Related]

  • 29. Effects of inducers of liver microsomal enzymes on the composition of microsomal hemoprotein.
    Kuntzman R, Alvares AP, Levin W.
    Adv Cytopharmacol; 1971 May 15; 1():241-7. PubMed ID: 5163245
    [No Abstract] [Full Text] [Related]

  • 30. Effects of inducers and inhibitors of cytochrome P-450-linked monooxygenases on the toxicity, in vitro metabolism and in vivo irreversible binding of 2-methylnaphthalene in mice.
    Griffin KA, Johnson CB, Breger RK, Franklin RB.
    J Pharmacol Exp Ther; 1982 Jun 15; 221(3):517-24. PubMed ID: 7086669
    [No Abstract] [Full Text] [Related]

  • 31. Metabolism of papaverine. III. Effect of phenobarbital, 3-methylcholanthrene and SKF 525-A pre-treated in vivo and in vitro.
    Belpaire FM, Bogaert MG.
    Xenobiotica; 1975 Jul 15; 5(7):431-8. PubMed ID: 1154810
    [Abstract] [Full Text] [Related]

  • 32. Induction and inhibition of the metabolism and biliary excretion of the azo dye carcinogen, N,N-dimethyl-4-aminoazobenzene (DAB), in the rat.
    Levine WG.
    Drug Metab Dispos; 1980 Jul 15; 8(4):212-7. PubMed ID: 6105053
    [Abstract] [Full Text] [Related]

  • 33. Effect of phenobarbital and 3-methylcholanthrene administration in vivo and isooctane extraction in vitro on metyrapone binding to reduced cytochrome P-450.
    Kahl R, Jonen HG, Kahl GF.
    Biochem Pharmacol; 1974 Aug 15; 23(16):2305-14. PubMed ID: 4851681
    [No Abstract] [Full Text] [Related]

  • 34. Studies on the biliary excretion of 14C-dicumarol in the rat.
    Husain S, Eisenbrandt LL, Wosilait WD.
    Drug Metab Dispos; 1973 Aug 15; 1(2):523-9. PubMed ID: 4132217
    [No Abstract] [Full Text] [Related]

  • 35. [Influence of ascorbic acid on the induction of monooxygenase in liver microsomes].
    Leber HW, Degkwitz E, Staudinger H.
    Hoppe Seylers Z Physiol Chem; 1970 Aug 15; 351(8):995-1001. PubMed ID: 5451288
    [No Abstract] [Full Text] [Related]

  • 36. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    Lettéron P, Fouin-Fortunet H, Tinel M, Danan G, Belghiti J, Pessayre D.
    J Pharmacol Exp Ther; 1984 Jun 15; 229(3):845-50. PubMed ID: 6547179
    [Abstract] [Full Text] [Related]

  • 37. The migration of deuterium during aryl hydroxylation. II. Effect of induction of microsomal hydroxylases with phenobarbital or polycyclic aromatic hydrocarbons.
    Daly J, Jerina D, Farnsworth J, Guroff G.
    Arch Biochem Biophys; 1969 Apr 15; 131(1):238-44. PubMed ID: 5781725
    [No Abstract] [Full Text] [Related]

  • 38. Factors influencing the microsomal metabolism of 3H-reserpine.
    Stawarz RJ, Stitzel RE.
    Pharmacology; 1974 Apr 15; 11(3):178-91. PubMed ID: 4151612
    [No Abstract] [Full Text] [Related]

  • 39. Interaction of modifiers of hepatic microsomal drug metabolism and the inhalation toxicity of 1,1-dichloroethylene.
    Carlson GP, Fuller GC.
    Res Commun Chem Pathol Pharmacol; 1972 Nov 15; 4(3):553-60. PubMed ID: 4344657
    [No Abstract] [Full Text] [Related]

  • 40. Effect of drugs which alter microsomal drug-metabolizing enzyme activity on rat hepatic cholesterol biosynthesis.
    Abernethy DR, Azarnoff DL.
    Biochem Pharmacol; 1977 Mar 15; 26(6):481-4. PubMed ID: 849344
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.